A new sugar-coupled 2-nitroimidazole derivative ([18F](see structure in text)) has been prepared in good radiochemical yields starting from peracetylated 2-[18F]FDG obtained from an automated 2-[18F]FDG production module. The corresponding glucose derivative (see structure in text) has proved to be able to inhibit 2-[18F]FDG uptake into tumor cells in a concentration dependent way. However, [18F](see structure in text) failed to show a retention in hypoxic tumor tissue thus excluding itself from further investigations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0969-8043(02)00186-0 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!